Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002049793-25-000001
Filing Date
2025-04-22
Accepted
2025-04-22 14:26:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7741
  Complete submission text file 0002049793-25-000001.txt   9658
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87880 | Film No.: 25857103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 412 GEORGIA AVE SUITE 201 CHATTANOOGA TN 37403
Business Address 412 GEORGIA AVE SUITE 201 CHATTANOOGA TN 37403 423-234-3460
Solas Tvardi Sidecar LLC (Filed by) CIK: 0002049793 (see all company filings)

EIN.: 332012855 | State of Incorp.: TN | Fiscal Year End: 1231
Type: SCHEDULE 13G